產(chǎn)品詳情
簡單介紹：
Anti-phospho-Rb2 p130 (Ser952)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-Rb2 p130 (Ser952)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-Rb2 p130 (Ser952)
Cat. Number:
Anti-phospho-Rb2 p130 (Ser952)抗體KL-17585R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
p130 is related both in structure and function to the retinoblastoma tumor suppressor protein and p107 (collectively known as pocket proteins) Anti-phospho-Rb2 p130 (Ser952)抗體and is known to regulate the activity of E2F transcription factors. E2F transcription factors regulate the expression of a number of genes important in cell proliferation, particularly those involved in the progression through G1 and into the S phase of the cell cycle. Binding of p130 converts E2F transcription factors from transcriptional activators to transcriptional repressors.
Also known as:
Rb2 p130 (phospho S952); p-Rb2 p130Anti-phospho-Rb2 p130 (Ser952)抗體 (phospho S952); p130; PRB2; Rb2; RBL2; RBR2; Retinoblastoma like 2; Retinoblastoma like protein 2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Anti-phospho-Rb2 p130 (Ser952)抗體Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KKLH conjugated synthesised phosphopeptide derived from human Rb2 p130 around the phosphorylation site of Ser952.
●
Predicted Molecular Weight: 128kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-Rb2 p130 (Ser952)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-phospho-Rb2 p130 (Ser952)抗體
Optimal working dilutions must be determined by the end user.
